Filing Details

Accession Number:
0001209191-15-003808
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-12 21:33:11
Reporting Period:
2015-01-08
Filing Date:
2015-01-12
Accepted Time:
2015-01-12 21:33:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1008848 Acorda Therapeutics Inc ACOR Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1532357 J. Enrique Carrazana 420 Saw Mill River Road
Ardsley NY 10502
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-01-08 6,715 $30.46 40,209 No 4 M Direct
Common Stock Disposition 2015-01-08 6,715 $42.01 33,494 No 4 S Direct
Common Stock Acquisiton 2015-01-09 16,803 $30.46 50,297 No 4 M Direct
Common Stock Acquisiton 2015-01-09 18,225 $26.35 68,522 No 4 M Direct
Common Stock Acquisiton 2015-01-09 42,879 $21.52 111,401 No 4 M Direct
Common Stock Disposition 2015-01-09 77,907 $42.11 33,494 No 4 S Direct
Common Stock Acquisiton 2015-01-12 13,371 $21.52 46,865 No 4 M Direct
Common Stock Disposition 2015-01-12 8,200 $42.61 38,665 No 4 S Direct
Common Stock Disposition 2015-01-12 5,171 $43.50 33,494 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2015-01-08 6,715 $0.00 6,715 $30.46
Common Stock Employee Stock Option (right to buy) Disposition 2015-01-09 16,803 $0.00 16,803 $30.46
Common Stock Employee Stock Option (right to buy) Disposition 2015-01-09 18,225 $0.00 18,225 $26.35
Common Stock Employee Stock Option (right to buy) Disposition 2015-01-09 42,879 $0.00 42,879 $21.52
Common Stock Employee Stock Option (right to buy) Disposition 2015-01-12 13,371 $0.00 13,371 $21.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,320 2023-03-06 No 4 M Direct
23,517 2023-03-06 No 4 M Direct
6,075 2022-03-15 No 4 M Direct
32,121 2021-10-15 No 4 M Direct
18,750 2021-10-15 No 4 M Direct
Footnotes
  1. Exercise and sales pursuant to a 10b5-1 plan.
  2. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $42.00 to $42.13 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $42.00 to $42.31 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  4. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $42.16 to $43.15 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  5. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $43.23 to $43.80 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  6. The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2013 with the first quarterly installment vested on April 1, 2013.
  7. The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2012 with the first quarterly installment vested on April 1, 2012.
  8. 25% of the shares subject to this option vested on October 15, 2012. The balance of the shares subject to this option vest in equal quarterly installments over the three years thereafter.